Eurofins Scientific SE (ERF):企業の財務・戦略的SWOT分析

◆英語タイトル:Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDBCS34964FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ルクセンブルク
◆産業分野:Business and Consumer Services
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Eurofins Scientific SE (ERF) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Eurofins Scientific SE (Eurofins) is a life sciences company, which provides analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, pharma early development, pharma central laboratory, biopharma product testing, agroscience services, product testing, forensic services and environmental testing. Its analytical methods help in evaluating the safety, identity, composition, origin, authenticity and purity of biological products and substances. It harnesses its expertise in logistics and information technology to deliver a range of services. The company operates across Western Europe, North America, and Rest of the World. Eurofins is headquartered in Luxembourg.

Eurofins Scientific SE Key Recent Developments

Mar 12,2021: Eurofins adds virus variant detection to its SARS-CoV-2 monitoring solution for wastewater, surface, air and worn masks
Feb 18,2021: Eurofins Scientific Announces Acquisition of Beacon Discovery, Substantially Expanding Its Integrated Drug Discovery Capabilities and Expertise
Feb 16,2021: Eurofins forensics adds significant covid-19 testing capacity to the UK with home testing roll-out
Jan 25,2021: Eurofins achieved revenues in excess of EUR 5.4bn in 2020, after continued momentum in December across both its core business and COVID-19 related activities
Dec 15,2020: Eurofins raises its 2020 objectives after strong momentum in its core business, as well as in COVID-19 related activities in October and November

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Eurofins Scientific SE – Key Facts
Eurofins Scientific SE – Key Employees
Eurofins Scientific SE – Key Employee Biographies
Eurofins Scientific SE – Major Products and Services
Eurofins Scientific SE – History
Eurofins Scientific SE – Company Statement
Eurofins Scientific SE – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Eurofins Scientific SE – Business Description
Product Category: BioPharmaceutical Services
Overview
Product Category: Clinical Diagnostics
Overview
Product Category: Consumer Product Testing
Overview
Product Category: Environmental Testing
Overview
Product Category: Eurofins Technologies
Overview
Product Category: Food and Feed Testing
Overview
Geographical Segment: Europe
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of the World
Performance
R&D Overview
Eurofins Scientific SE – SWOT Analysis
SWOT Analysis – Overview
Eurofins Scientific SE – Strengths
Eurofins Scientific SE – Weaknesses
Eurofins Scientific SE – Opportunities
Eurofins Scientific SE – Threats
Eurofins Scientific SE – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Eurofins Scientific SE, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 12, 2021: Eurofins adds virus variant detection to its SARS-CoV-2 monitoring solution for wastewater, surface, air and worn masks
Feb 16, 2021: Eurofins forensics adds significant covid-19 testing capacity to the UK with home testing roll-out
Jan 25, 2021: Eurofins achieved revenues in excess of EUR 5.4bn in 2020, after continued momentum in December across both its core business and COVID-19 related activities
Dec 15, 2020: Eurofins raises its 2020 objectives after strong momentum in its core business, as well as in COVID-19 related activities in October and November
Dec 09, 2020: Eurofins Biopharma product testing expands its virucidal testing capacity
Nov 05, 2020: Eurofins CDMO announces expansion of drug product capabilities in Canada
Nov 02, 2020: Eurofins Discovery announces collaboration with Swiss Biotech Amphilix
Oct 22, 2020: Eurofins reports very strong performance with organic growth exceeding 22% in Q3 2020 and sets new objectives for 2022
Oct 16, 2020: Eurofins Biomnis to create additional capacity of 15,000 tests per day carried out within 24 hours to help combat the second wave of the Covid-19 pandemic
Oct 06, 2020: Eurofins launches Europe’s first validated test method to evaluate filtration capacity of masks for SARS-CoV-2
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Eurofins Scientific SE, Key Facts
Eurofins Scientific SE, Key Employees
Eurofins Scientific SE, Key Employee Biographies
Eurofins Scientific SE, Major Products and Services
Eurofins Scientific SE, History
Eurofins Scientific SE, Subsidiaries
Eurofins Scientific SE, Key Competitors
Eurofins Scientific SE, Ratios based on current share price
Eurofins Scientific SE, Annual Ratios
Eurofins Scientific SE, Annual Ratios (Cont...1)
Eurofins Scientific SE, Annual Ratios (Cont...2)
Eurofins Scientific SE, Interim Ratios
Eurofins Scientific SE, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Eurofins Scientific SE (ERF):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and botanical drugs. It also offers drugs such as xue …
  • Weyerhaeuser Company:企業の戦略・SWOT・財務情報
    Weyerhaeuser Company - Strategy, SWOT and Corporate Finance Report Summary Weyerhaeuser Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Alcon Inc (ALC):企業の財務・戦略的SWOT分析
    Alcon Inc (ALC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • MKB Private Banking:企業の戦略・SWOT・財務分析
    MKB Private Banking - Strategy, SWOT and Corporate Finance Report Summary MKB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ralph Lauren Corporation:戦略・SWOT・企業財務分析
    Ralph Lauren Corporation - Strategy, SWOT and Corporate Finance Report Summary Ralph Lauren Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Colonial Pipeline Company:石油・ガス:M&Aディール及び事業提携情報
    Summary Colonial Pipeline Company (Colonial) is an oil and gas company that distributes petroleum products. The company transports refined petroleum products such as gasoline, home-heating oil, kerosene, diesel fuels; and aviation fuel including jet fuel and military fuels. It provides services incl …
  • New Zealand Oil & Gas Ltd (NZO):企業の財務・戦略的SWOT分析
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas that offers oil and gas exploration, development and production. The company acquires, explores, and develops crude oil and natural gas properties. Its producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampa …
  • Sunstar Holding AG:企業の戦略・SWOT・財務情報
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Fidia farmaceutici SpA-製薬・医療分野:企業M&A・提携分析
    Summary Fidia farmaceutici SpA (Fidia), a subsidiary of P&R S.p.A., is a healthcare products provider that specializes in research, development and manufacturing of hyaluronic acid-based products. The company develops and commercializes products for specific therapeutic areas which includes joint he …
  • Vaccibody AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccibody AS (Vaccibody) is a vaccine company that provides discovery and development of novel immunotherapies, prophylactic and therapeutic vaccines. The company develops VB10.16, a DNA based immunotherapy targeting malignancies caused by human papilloma virus. It conducts exploratory safet …
  • Purdue Pharma L.P.:企業のM&A・事業提携・投資動向
    Purdue Pharma L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Purdue Pharma L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • SPAGO Nanomedical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Spago Nanomedical AB (Spago Nanomedical), formerly Spago Imaging AB is a research and development company that develops nanomedical products for the diagnosis and treatment of cancer. The company offers spagopix, a magnetic resonance imaging contrast agent to improve the visualization of sof …
  • 1-800-FLOWERS.COM, Inc. (FLWS):企業の財務・戦略的SWOT分析
    1-800-FLOWERS.COM, Inc. (FLWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • High Arctic Energy Services Inc (HWO):企業の財務・戦略的SWOT分析
    Summary High Arctic Energy Services Inc (High Arctic) operates as an oil and gas company that provides drilling services and equipment for rentals. The company provides services such as drilling services, matting and equipment rentals, snubbing services and nitrogen services. It offers equipment ren …
  • The Medicines Company (MDCO):製薬・医療:M&Aディール及び事業提携情報
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products a peptide compound that inhibits an intravenous direct thrombin and needle …
  • Valence Health-製薬・医療分野:企業M&A・提携分析
    Summary Valence Health is a healthcare company that provides healthcare services. The company offers solutions such as consulting, vision platform, quality measurement, cost and utilization, data collection, contract administration, managed services, and actuarial services. It provides health care s …
  • Daepyung Co., Ltd.:企業の戦略・SWOT・財務情報
    Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nerviano Medical Sciences Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Nerviano Medical Sciences Srl (NMS) is a drug development company that discovers and develops novel anticancer drugs. The company's pipeline products include anticancer compounds such as Danusertib, Encorafenib, Entrectinib, ADC Payload programs, PARP1 program, NMS-088, Brostallicin, Milcicl …
  • EnviroMission Limited:企業の戦略的SWOT分析
    EnviroMission Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • The E. W. Scripps Company:企業の戦略・SWOT・財務分析
    The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report Summary The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆